TissGeneSummary for CCL26 |
Gene summary |
Basic gene information | Gene symbol | CCL26 |
Gene name | chemokine (C-C motif) ligand 26 | |
Synonyms | IMAC|MIP-4a|MIP-4alpha|SCYA26|TSC-1 | |
Cytomap | UCSC genome browser: 7q11.23 | |
Type of gene | protein-coding | |
RefGenes | NM_006072.4, | |
Description | C-C motif chemokine 26CC chemokine IMACMIP-4-alphachemokine N1eotaxin-3macrophage inflammatory protein 4-alphasmall inducible cytokine A26small inducible cytokine subfamily A (Cys-Cys), member 26small-inducible cytokine A26thymic stroma chemokine | |
Modification date | 20141207 | |
dbXrefs | MIM : 604697 | |
HGNC : HGNC | ||
Ensembl : ENSG00000006606 | ||
HPRD : 05262 | ||
Vega : OTTHUMG00000130403 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CCL26 | |
BioGPS: 10344 | ||
Pathway | NCI Pathway Interaction Database: CCL26 | |
KEGG: CCL26 | ||
REACTOME: CCL26 | ||
Pathway Commons: CCL26 | ||
Context | iHOP: CCL26 | |
ligand binding site mutation search in PubMed: CCL26 | ||
UCL Cancer Institute: CCL26 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | OvaryEye | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | OVUVM | |
Reference showing the relevant tissue of CCL26 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0001938 | positive regulation of endothelial cell proliferation | 19525930 | GO:0030335 | positive regulation of cell migration | 19525930 | GO:0030838 | positive regulation of actin filament polymerization | 19525930 | GO:0032855 | positive regulation of Rac GTPase activity | 19525930 | GO:0001938 | positive regulation of endothelial cell proliferation | 19525930 | GO:0030335 | positive regulation of cell migration | 19525930 | GO:0030838 | positive regulation of actin filament polymerization | 19525930 | GO:0032855 | positive regulation of Rac GTPase activity | 19525930 |
Top |
TissGeneExp for CCL26 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LUSC | 1.503343187 | -0.927133283 | 2.430476471 | 6.60E-12 | 2.81E-11 |
LUAD | 0.170137609 | -1.09403308 | 1.26417069 | 5.09E-06 | 1.54E-05 |
THCA | -0.691376155 | -1.837498188 | 1.146122034 | 2.87E-08 | 1.34E-07 |
KICH | -2.14314246 | -0.43944646 | -1.703696 | 2.51E-08 | 1.25E-07 |
HNSC | 1.630599959 | 0.629446471 | 1.001153488 | 0.0101 | 0.024972527 |
COAD | 0.568910156 | -0.955247537 | 1.524157692 | 0.000456 | 0.001421189 |
LIHC | -1.13737846 | -2.18984646 | 1.052468 | 0.000206 | 0.000656422 |
Top |
TissGene-miRNA for CCL26 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for CCL26 |
TissGeneSNV for CCL26 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.E51K | SKCM | 1 |
p.R48X | PAAD | 1 |
p.K83* | SKCM | 1 |
p.L94V | COAD | 1 |
p.L42F | BLCA | 1 |
p.A61V | LGG | 1 |
p.L12M | COAD | 1 |
p.R77K | LGG | 1 |
p.R48* | PAAD | 1 |
p.T53S | LUSC | 1 |
Top |
TissGeneCNV for CCL26 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for CCL26 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for CCL26 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for CCL26 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for CCL26 |
TissGeneDrug for CCL26 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for CCL26 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0004096 | Asthma | 15 | BeFree,GAD |
umls:C0341106 | Eosinophilic esophagitis | 9 | BeFree,CTD_human |
umls:C0014457 | Eosinophilia | 6 | BeFree |
umls:C1306759 | Eosinophilic disorder | 6 | BeFree |
umls:C1636667 | Disorder characterized by eosinophilia | 6 | BeFree |
umls:C0009324 | Ulcerative Colitis | 3 | BeFree,GAD,LHGDN |
umls:C0003873 | Rheumatoid Arthritis | 2 | BeFree,GAD |
umls:C0011603 | Dermatitis | 2 | BeFree |
umls:C0011615 | Dermatitis, Atopic | 2 | BeFree |
umls:C0013595 | Eczema | 2 | BeFree |
umls:C0014868 | Esophagitis | 2 | LHGDN |
umls:C0017168 | Gastroesophageal reflux disease | 2 | BeFree,LHGDN |
umls:C0021390 | Inflammatory Bowel Diseases | 2 | BeFree,LHGDN |
umls:C0027430 | Nasal Polyps | 2 | BeFree |
umls:C0041341 | Tuberous Sclerosis | 2 | BeFree |
umls:C0149516 | Chronic sinusitis | 2 | BeFree |
umls:C0699949 | airway disease | 2 | BeFree |
umls:C0006274 | Bronchiolitis, Viral | 1 | GAD |
umls:C0008728 | Churg-Strauss Syndrome | 1 | BeFree |
umls:C0011168 | Deglutition Disorders | 1 | BeFree |
umls:C0019693 | HIV Infections | 1 | GAD |
umls:C0021368 | Inflammation | 1 | LHGDN |
umls:C0024899 | Mastocytosis | 1 | BeFree |
umls:C0032285 | Pneumonia | 1 | BeFree |
umls:C0035235 | Respiratory Syncytial Virus Infections | 1 | GAD |
umls:C0036429 | Sclerosis | 1 | LHGDN |
umls:C0042111 | Urticaria Pigmentosa | 1 | BeFree |
umls:C0042384 | Vasculitis | 1 | BeFree |
umls:C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | BeFree |
umls:C0155877 | Allergic asthma | 1 | BeFree |
umls:C0279626 | Squamous cell carcinoma of esophagus | 1 | BeFree |
umls:C0877430 | Asthma chronic | 1 | BeFree |
umls:C2985318 | Pregnancy Related Skin Change | 1 | BeFree |
umls:C3714514 | Infection | 1 | LHGDN |